This site contains the South Australian Clinical Prioritisation Criteria (CPC) for most frequently referred Gynaecology and Gynaecology Oncology conditions.

Gynaecology and gynaecology oncology conditions

Please note this is not an exhaustive list of all conditions for outpatient services and does not exclude consideration for referral unless specifically stipulated in the gynaecology and gynaecology oncology exclusions section.

Out of scope

Not all medical conditions are covered by the CPC, as certain conditions may be considered out of scope or managed by other specialist services:

Exclusions for public specialist outpatient services

Not all gynaecology and gynaecology oncology conditions are appropriate for referral into the South Australian public health system. The following are not routinely provided in a public specialist outpatient service:

  • Asymptomatic labial adhesions
  • Cosmetic surgery
  • Heavy menstrual bleeding without trial of first-line treatment
  • Implanon removal
  • Labial surgery for cosmetic, personal or comfort reasons
  • Pelvic pain without trial of first-line treatment
  • Recurrent ovarian cysts without trial of hormonal contraception history/use
  • Reversal of sterilisation
  • Routine contraceptive or menopausal advice
  • Routine gynaecological check-up
  • Routine human papillomavirus (HPV) testing/ cervical screening test (CST)
  • Simple cyst less than 5cm in size and normal ca 125
  • Single episode of post-coital bleeding with normal CST and liquid based cytology without oncogenic HPV
  • Vulval disorders without a trial of first-line treatment
  • Women experiencing less than 2 miscarriages
  • Women undergoing test of cure for non-16/18 HPV
  • Women with intermenstrual bleeding (IMB) who have not trialled first-line treatment

Emergency information

See the individual condition pages for more specific emergency information.


We welcome requests for further information or feedback on the CPC and website, please refer to the relevant form below.

Please email the completed form to


The Gynaecology and Gynaecology Oncology CPC is due for review in September 2025.

Evidence statement